Current Prices from Anbio Biotechnology - Class A Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	NNNN	USD	06.06.2025 19:59	8,57 USD	8,36 USD +2,51 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	11,73 %	30,40 %	20,20 %	23,49 %	23,49 %	23,49 %

Company Profile for Anbio Biotechnology - Class A Ordinary Shares Share

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Company Data

Name Anbio Biotechnology - Class A Ordinary Shares

Company Anbio Biotechnology Class A Ordinary Shares

Symbol NNNN

Website https://www.anbio.com

Primary Exchange

NASDAQ

ISIN KYG0367B1059

Asset Class Share

Sector Healthcare

Industry Medical - Instruments & Supplies

CEO Mr. Michael Lau M.B.A., Ph.D.

Market Capitalization 283 Mio

Country Germany

Currency USD

Employees -

Address Wilhelm Gutbrod Str 21B, 60437 Frankfurt am Main

IPO Date 2025-02-19

Ticker Symbols

Name	Symbol
Frankfurt	N3B.F
NASDAQ	NNNN

More Shares

Investors who Anbio Biotechnology - Class A Ordinary Shares hold also have the following shares in their portfolio:

DZ BANK CLN E.10609 Bond

LOWE'S CO 13/43 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog